A national analysis of time-use diaries finds social time and exercise correlate with "better than typical" days. Local residents say morning workouts and quick catch-ups do the trick.

A preliminary Health Policy Commission review found the MGB–CVS MinuteClinic affiliation could raise commercial health care spending by about $40 million a year while reshaping clinic services.

Lahey is expanding catheter‑based valve care — TAVR plus new mitral and tricuspid options — letting many patients avoid open‑heart surgery and shorten recovery.

State immunization data show overall coverage is stable, but rising religious waivers and under‑vaccinated pockets in places like Dukes and Franklin counties raise outbreak risks.

A federal recall covers about 356,140 VitaQuest-made iron supplements because caps aren't child-resistant; VitaQuest is offering free childproof caps and a full lot chart is available.

A Boston nurse’s persistent headaches were diagnosed as idiopathic intracranial hypertension; new MRI research from Mass General Brigham points to less invasive diagnostic clues. Researchers are also studying GLP‑1 drugs as a possible treatment.

McLean Hospital's HabitWorks helped users shift negative thinking and improved daily functioning in a 340-person nationwide trial, and the team plans a wider release after more study.

Merrimack Health filed to close the Methuen maternity unit and move birthing care to Lawrence Hospital; the filing starts a 120‑day state review and public hearing process.

The CDC posted a Level 1 global dengue travel notice after rising cases among travelers. Bite prevention and quick medical care are the main defenses.

An analysis of PROMISE trial CT scans found women’s heart risk rises at lower plaque burdens than men, even though women had less plaque overall. Researchers say sex-specific thresholds may be needed.

State figures show abortions more than doubled in Massachusetts as telehealth and out‑of‑state patients surged, reshaping where people get care.

A Senate report and Boston Children’s surveys say GSK’s removal of Flovent left some children with worse asthma control and higher bills even as a generic is approved.

Older adults are boosting sales at Massachusetts dispensaries, while doctors warn about potency and dosing risks.